Immunocore Reveals First Data From HIV Infection Candidate Study
Immunocore Holdings plc (NASDAQ:IMCR) has presented the first safety and activity data with IMC-M113V, a bispecific soluble TCR therapy built on…
Fresenius Medical Care Q4 Profit Slips Despite Higher Revenue, Simplifies Structure
Fresenius Medical Care AG & Co (NYSE:FMS) has implemented its new operating model with two global segments: Care Enablement (Health Care…
US Supreme Court Refuses To Reject $302M Judgment Against Johnson & Johnson Over Pelvic Mesh Marketing
The U.S. Supreme Court refused to hear Johnson & Johnson's (NYSE: JNJ) regarding a $302 million judgment in a lawsuit brought by California, accusing the company of concealing the risks of its pelvic mesh products.
Analyst Says Ionis’ Additional Hereditary Angioedema Study Data Supports ‘Highly Competitive Profile’
Ionis Pharmaceuticals Inc (NASDAQ:IONS) announced additional interim data from a Phase 2 open-label extension (OLE) study of donidalorsen for hereditary angioedema. …
Aileron Therapeutics Shelves Development On Chemoprotection Agent, Shares Fall
Aileron Therapeutics (NASDAQ:ALRN) announced that a review of initial data from its Phase 1b chemoprotection trial of ALRN-6924 in p53-mutated breast…
Merck’s COVID-19 Treatment Fails To Prevent Infection In Household Exposure
Merck & Co Inc (NYSE:MRK) Lagevrio (molnupiravir) did not demonstrate a statistically significant reduction in the risk of COVID-19 following household…
Corvus Pharma’s HIV Candidate Shows Potential To Prevent Virus Re-Emergence
Corvus Pharmaceuticals Inc (NASDAQ:CRVS) announced new data demonstrating the potential of CPI-818, an ITK inhibitor, to reduce the need for chronic…
FDA Gives Green Signal To Chemomab Therapeutics’ Rare Disease Study
The FDA has signed off Chemomab Therapeutics Ltd’s (NASDAQ:CMMB) Investigational New Drug (IND) Application to evaluate CM-101 in a Phase 2…
Why Are Apellis Pharmaceuticals Shares Trading Higher Today?
The FDA approved Apellis Pharmaceuticals Inc’s (NASDAQ:APLS) Syfovre (pegcetacoplan injection) for geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Syfovre…
SEC’s Actions Against Binance Stablecoin Issuer May Have Major Implications On $137B Market
The Securities and Exchange Commission is reportedly preparing to take action against Paxos Trust Co, which could probably have significant implications for all stablecoins, including tether and USDC, the two largest, which are worth $110 billion combined.